Pulmatrix Statistics
Total Valuation
Pulmatrix has a market cap or net worth of $5.11 million. The enterprise value is $1.06 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmatrix has 3.65 million shares outstanding.
| Current Share Class | 3.65M |
| Shares Outstanding | 3.65M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 9.89% |
| Float | 3.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.55
| Current Ratio | 12.55 |
| Quick Ratio | 12.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -80.93% and return on invested capital (ROIC) is -50.65%.
| Return on Equity (ROE) | -80.93% |
| Return on Assets (ROA) | -45.88% |
| Return on Invested Capital (ROIC) | -50.65% |
| Return on Capital Employed (ROCE) | -135.67% |
| Weighted Average Cost of Capital (WACC) | 15.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.58M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.81% in the last 52 weeks. The beta is 1.97, so Pulmatrix's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -77.81% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 3.75 |
| Relative Strength Index (RSI) | 42.17 |
| Average Volume (20 Days) | 83,229 |
Short Selling Information
The latest short interest is 8,053, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 8,053 |
| Short Previous Month | 2,505 |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | -38,000 |
| Operating Income | -5.17M |
| Pretax Income | -5.16M |
| Net Income | -5.16M |
| EBITDA | -5.06M |
| EBIT | -5.17M |
| Earnings Per Share (EPS) | -$1.41 |
Full Income Statement Balance Sheet
The company has $4.09 million in cash and n/a in debt, with a net cash position of $4.09 million or $1.12 per share.
| Cash & Cash Equivalents | 4.09M |
| Total Debt | n/a |
| Net Cash | 4.09M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 3.81M |
| Book Value Per Share | 1.04 |
| Working Capital | 3.80M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -5.43M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 106,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.43M |
| FCF Per Share | -$1.49 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |